<i>In silico</i>and<i>in vitro</i>evaluation of exonic and intronic off-target effects form a critical element of therapeutic ASO gapmer optimizationPiotr J. Kamola, Joel D. Parry, Paul A. Wilson et al.|Nucleic Acids Research|2015Cited by 109
Strategies for In Vivo Screening and Mitigation of Hepatotoxicity Associated with Antisense DrugsPiotr J. Kamola, Joel D. Parry, Mark R. Edbrooke et al.|Molecular Therapy — Nucleic Acids|2017Cited by 62
Pharmacological Characterization of a Novel ENaCα siRNA (GSK2225745) With Potential for the Treatment of Cystic FibrosisKenneth L. Clark, Mark R. Edbrooke, Chris Gruenloh et al.|Molecular Therapy — Nucleic Acids|2013Cited by 37